Assessment of tumoral plasma cells in apheresis products for autologous stem cell transplantation in multiple myeloma

Bone Marrow Transplant. 2016 Aug;51(8):1143-5. doi: 10.1038/bmt.2016.74. Epub 2016 Apr 4.

Authors

S Wuillème¹, A Lok², N Robillard¹, P Dupuis³, V Stocco³, H Migné¹, A Dusquesne³, C Touzeau², M Tiab⁴, M C Béné¹, P Moreau²

Affiliations

¹ Hematology Biology, Nantes University Hospital, Nantes, France.
² Clinical Hematology, Nantes University Hospital, Nantes, France.
³ Cell Therapy, Etablissement Français du Sang, Nantes, France.
⁴ Clinical Hematology, Regional Hospital of Vendée, La Roche sur Yon, France.

PMID: 27042840
DOI: 10.1038/bmt.2016.74

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Blood Component Removal / standards*
Female
Flow Cytometry
Hematopoietic Stem Cell Transplantation / methods
Hematopoietic Stem Cell Transplantation / standards*
Humans
Male
Middle Aged
Multiple Myeloma / mortality
Multiple Myeloma / therapy*
Plasma Cells / pathology*
Plasmacytoma / pathology
Prospective Studies
Survival Analysis
Transplantation, Autologous*